Literature DB >> 15476267

Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis.

Dirk Foell1, José Hernández-Rodríguez, Montse Sánchez, Thomas Vogl, Maria C Cid, Johannes Roth.   

Abstract

Vascular inflammation in giant cell arteritis is generally described as a process involving dendritic cells, T-lymphocytes, and effector tissue macrophages. Less is known about the contribution of phagocytes that are recruited early, such as monocytes and neutrophils. These cells express and secrete pro-inflammatory S100 proteins which directly activate endothelial cells. In this study the expression of S100A8/S100A9 and S100A12, pro-inflammatory proteins specific for early recruited phagocytes, was studied in biopsies from 36 patients with giant cell arteritis. In addition, serum concentrations of these proteins were analysed in serum samples from 42 patients and 35 healthy controls. The S100A8/S100A9 complex was found to be abundant in the adventitia and media in affected arteries. Besides neutrophils, cells expressing these proteins belonged to a pro-inflammatory subtype of CD68-positive monocytes. In contrast, S100A12 expression was restricted to neutrophils that were found around the vasa vasorum within the adventitial layer. Both S100A8/S100A9 and S100A12 serum concentrations were significantly higher in patients with giant cell arteritis than in healthy controls. In conclusion, recently recruited phagocytes expressing pro-inflammatory S100 proteins take part in the vascular inflammation of giant cell arteritis. They may play important roles at the vasa vasorum of affected vessels, which represent sites of entry for recruited inflammatory cells. These data indicate that phagocytes within the adventitia and media contribute to the process of inflammation via release of the pro-inflammatory S100 proteins S100A8, S100A9, and S100A12. Copyright (c) 2004 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476267     DOI: 10.1002/path.1660

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  27 in total

Review 1.  [Translational research in pediatric rheumatology. Current research approaches to the innate immune system].

Authors:  K Lippitz; J Waldkirch; C Kessel; G Varga; D Foell
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

2.  Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.

Authors:  T Kaiser; J Langhorst; H Wittkowski; K Becker; A W Friedrich; A Rueffer; G J Dobos; J Roth; D Foell
Journal:  Gut       Date:  2007-08-03       Impact factor: 23.059

3.  S100A8+ stroma cells predict a good prognosis and inhibit aggressiveness in colorectal carcinoma.

Authors:  Si Li; Fangying Xu; Hui Li; Jing Zhang; Anjing Zhong; Bin Huang; Maode Lai
Journal:  Oncoimmunology       Date:  2016-12-12       Impact factor: 8.110

Review 4.  Calprotectin in rheumatic diseases.

Authors:  Francesca Ometto; Lara Friso; Davide Astorri; Costantino Botsios; Bernd Raffeiner; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

5.  MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.

Authors:  Helmut Wittkowski; Jasmin B Kuemmerle-Deschner; Judith Austermann; Dirk Holzinger; Raphaela Goldbach-Mansky; Katharina Gramlich; Peter Lohse; Thomas Jung; Johannes Roth; Susanne M Benseler; Dirk Foell
Journal:  Ann Rheum Dis       Date:  2011-09-08       Impact factor: 19.103

Review 6.  Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Dario Camellino; Eric L Matteson; Frank Buttgereit; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

7.  S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways.

Authors:  X Xu; H Chen; X Zhu; Y Ma; Q Liu; Y Xue; H Chu; W Wu; J Wang; H Zou
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

8.  Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.

Authors:  Mario Gössl; Jörg Herrmann; Hui Tang; Daniele Versari; Offer Galili; Dallit Mannheim; S Vincent Rajkumar; Lilach O Lerman; Amir Lerman
Journal:  Basic Res Cardiol       Date:  2009-05-21       Impact factor: 17.165

9.  S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin.

Authors:  Helmut Wittkowski; Michael Frosch; Nico Wulffraat; Raphaela Goldbach-Mansky; Tilmann Kallinich; Jasmin Kuemmerle-Deschner; Michael C Frühwald; Sandra Dassmann; Tuyet-Hang Pham; Johannes Roth; Dirk Foell
Journal:  Arthritis Rheum       Date:  2008-12

10.  Bioinorganic Explorations of Zn(II) Sequestration by Human S100 Host-Defense Proteins.

Authors:  Lisa S Cunden; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2018-03-06       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.